Grace & White Inc’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-14,705
| Closed | -$9.19K | – | 150 |
|
|
2023
Q1 | $9.19K | Hold |
14,705
| – | – | ﹤0.01% | 137 |
|
|
2022
Q4 | $11.5K | Hold |
14,705
| – | – | ﹤0.01% | 129 |
|
|
2022
Q3 | $10K | Sell |
14,705
-10,600
| -42% | -$7.21K | ﹤0.01% | 129 |
|
|
2022
Q2 | $16K | Hold |
25,305
| – | – | ﹤0.01% | 129 |
|
|
2022
Q1 | $18K | Hold |
25,305
| – | – | ﹤0.01% | 130 |
|
|
2021
Q4 | $18K | Hold |
25,305
| – | – | ﹤0.01% | 131 |
|
|
2021
Q3 | $32K | Hold |
25,305
| – | – | 0.01% | 131 |
|
|
2021
Q2 | $37K | Hold |
25,305
| – | – | 0.01% | 128 |
|
|
2021
Q1 | $38K | Buy |
25,305
+14,705
| +139% | +$22.1K | 0.01% | 126 |
|
|
2020
Q4 | $16K | Buy |
+10,600
| New | +$16K | ﹤0.01% | 126 |
|